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Abstract
Background: Because some adverse health effects associated with chronic arsenic exposure may be mediated by
methylated arsenicals, interindividual variation in capacity to convert inorganic arsenic into mono- and di-methylated
metabolites may be an important determinant of risk associated with exposure to this metalloid. Hence, identifying
biological and behavioral factors that modify an individual’s capacity to methylate inorganic arsenic could provide
insights into critical dose-response relations underlying adverse health effects.
Methods: A total of 904 older adults (≥45 years old) in Churchill County, Nevada, who chronically used home tap water
supplies containing up to 1850 μg of arsenic per liter provided urine and toenail samples for determination of total and
speciated arsenic levels. Effects of biological factors (gender, age, body mass index) and behavioral factors (smoking,
recent fish or shellfish consumption) on patterns of arsenicals in urine were evaluated with bivariate analyses and
multivariate regression models.
Results: Relative contributions of inorganic, mono-, and di-methylated arsenic to total speciated arsenic in urine were
unchanged over the range of concentrations of arsenic in home tap water supplies used by study participants. Gender
predicted both absolute and relative amounts of arsenicals in urine. Age predicted levels of inorganic arsenic in urine
and body mass index predicted relative levels of mono- and di-methylated arsenic in urine. Smoking predicted both
absolute and relative levels of arsenicals in urine. Multivariate regression models were developed for both absolute and
relative levels of arsenicals in urine. Concentration of arsenic in home tap water and estimated water consumption were
strongly predictive of levels of arsenicals in urine as were smoking, body mass index, and gender. Relative contributions
of arsenicals to urinary arsenic were not consistently predicted by concentrations of arsenic in drinking water supplies
but were more consistently predicted by gender, body mass index, age, and smoking.
Conclusions: These findings suggest that analyses of dose-response relations in arsenic-exposed populations should
account for biological and behavioral factors that modify levels of inorganic and methylated arsenicals in urine. Evidence
of significant effects of these factors on arsenic metabolism may also support mode of action studies in appropriate
experimental models.
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Background
In a study population of older adults from Churchill
County, Nevada, we have previously examined rela-
tions between dose (measured by the total arsenic
(TAs) concentration in home tap water) and response
(measured as summed urinary concentrations of spe-
ciated arsenicals) and modification of these relations
by both biological (e.g., gender) and behavioral (e.g.,
smoking) factors [1]. Although informative, this ana-
lysis did not directly examine dose-response relations
for individual urinary metabolites of inorganic arsenic
(iAs) or effects of modifying factors on urinary levels
of iAs and its monomethylated (MMA) and dimethy-
lated (DMA) metabolites. These relations and their
modification by biological and behavioral factors may
be significant in assessing the consequences of
chronic exposure to iAs. For example, methylation of
iAs affects patterns of tissue distribution and facili-
tates the clearance of arsenic in humans and other
species [2–5]. In humans, genotypic variation in
AS3MT which encodes the enzyme that catalyzes re-
actions that methylate arsenic in humans has been
linked to differences in urinary profiles of iAs and its
methylated metabolites and to variation in disease
susceptibility [6, 7]. Thus, characterizing effects of
biological and behavioral factors on these dose-
response relations may clarify their contributions to
interindividual variation in capacity to convert iAs
into methylated metabolites.
Churchill County, Nevada, presented a unique op-
portunity to evaluate the influence of these factors in
a relatively large number of study participants (904)
who were chronically exposed to TAs through home
tap water supplies. Here, levels of TAs exposure in
home tap water ranged from below the analytical
limit of detection (LOD) to levels that have been con-
sistently associated with health effects in other popu-
lations [8–10]. The present study characterized
urinary excretion of iAs and its methylated metabo-
lites in older adults who were chronically exposed to
TAs through home tap water supplies. This study
evaluated several biological factors (gender, age, body
mass index (BMI) and behavioral factors (smoking,
recent fish or shellfish consumption) as potential
modifiers of urinary iAs, MMA, and DMA concentra-
tions. These analyses found that all biological factors
and a behavioral factor, smoking behavior, significantly
affected absolute or relative levels of iAs or its meth-
ylated metabolites in urine. These modifying factors
may contribute to variability among individuals in
profiles of arsenicals in urine and in interindividual
differences in susceptibility to adverse health effects
associated with chronic exposure to iAs. Future stud-
ies of dose-response relations in exposed human
populations should consider these modifiers on pat-
terns of urinary arsenicals to assure accurate attribu-
tions of health effects.
Methods
Study design, sample collection and processing
Demographic characteristics of study participants are
briefly summarized in the Additional file 1 and more
fully elsewhere [1]. At the time of this study (August and
September 2002), TAs concentration in the drinking
water supply of Fallon, the largest city in Churchill County,
exceeded the then-current maximum contaminant level
(MCL) of 50 μg of TAs per liter [11]. Historically, TAs
concentration in Fallon’s municipal water supply was
around 100 μg per liter; during this study, the mean
concentration was 89 μg per liter. To broaden the range of
TAs exposures, participants includes users of the Fallon
municipal water supply and individuals who resided
elsewhere in Churchill County where TAs concentrations
in home tap water supplies ranged from below the LOD
(3 μg per liter) to 1850 μg per liter. Among 904 study
participants, 250 used the municipal water supply, 613
used individual residential wells, and 41 used shared
residential wells.
Criteria for enrollment in this study were an age of
at least 45 years, continuous residency in Churchill
County for 5 years at the time of enrollment, and cu-
mulative residency of at least 20 years in the county.
At enrollment, participants provided written consent
to a study protocol approved by the Institutional
Review Board of the University of North Carolina at
Chapel Hill and reviewed by the U.S. EPA Human
Subjects Protection Office.
Each participant provided a urine sample, a blood
sample, and completed an exposure assessment and
medical history questionnaire that requested demo-
graphic information, medical history, information on
recent and habitual seafood consumption, length of
residence in their present home, and any point-of-use
treatment of home tap water or use of commercially
bottled water. Participants reported daily water con-
sumption, drug, alcohol, or tobacco usage, and poten-
tial environmental or occupational exposure to
arsenic. Participants received a home collection kit
for toenails and a container for an untreated home
tap water sample. Home tap water samples were col-
lected as described in Additional file 1. Urine samples
were initially stored at 4 °C, shipped to North Carolina on
dry ice, and stored at −80 °C until analyzed. Blood samples
collected in EDTA-containing Vacutainer tubes (Becton-
Dickson, Franklin Lakes, NJ) were initially stored at 4 °C,
shipped to North Carolina on refrigerant packs, and then
stored at 4 °C until processed.
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Total arsenic in drinking water
TAs concentrations in home tap water samples were de-
termined by Environmental Protection Agency Method
200.8 [12] or by ASTM method D2972 [13] in the State
Health Laboratory, Bureau of Health Protection Services,
Reno, Nevada. This laboratory, accredited by US EPA
Region IX, used quality assurance and quality control
procedures that met Safe Drinking Water Act guidelines.
Speciated arsenicals in urine
Urinary concentrations of arsenite (iAsIII) arsenate
(iAsV), monomethylarsonic acid (MMAV) and dimethylar-
sinic acid (DMAV) were determined by ion-pair chromato-
graphic separation with hydride generation-atomic
fluorescence detection [14] as described in Additional file 1.
Concentrations of these urinary metabolites were expressed
on a parts per billion basis without correction for urinary
creatinine concentration or specific gravity. Limits of
detection for iAsIII and MAsV were 0.5 μg/l; for iAsV and
DMAsV, 1 μg/l.
Toenail total arsenic
Total arsenic concentrations in toenail samples (NTAs)
were determined by instrumental neutron activation
analysis and expressed as parts per million of arsenic [1].
Sample collection, processing, and analysis are described
in Additional file 1.
Urinary cotinine and creatinine
Urinary cotinine levels were used to assess cigarette
smoking. Urinary cotinine concentrations were deter-
mined by radioimmunoassay [15, 16]. Except for cre-
ating a smoking/non-smoking categorical variable
from creatinine-corrected urinary cotinine concentra-
tions that was used for the stepwise selection, urinary
concentrations of arsenicals and cotinine were not
corrected for creatinine concentration. Methods for
determination of cotinine and creatinine in urine are
described in Additional file 1.
Imputation of non-detects and missing values
Samples with the concentration of an analyte below the
LOD were designated as non-detect samples. Concentra-
tions in non-detect samples and other missing values
were imputed for the analysis. Imputation of analyte
concentrations in non-detect samples assumed that
analyte concentrations were log-normally distributed
and the distribution of concentrations in the non-detect
samples resembled the portion of the log-normal
distribution below the detection limit. In 21 tap water
samples, TAs was below the LOD and in 52 toenail sam-
ples NTAs was below the LOD. Among urine samples,
iAsIII and iAsV were not detected in 289 and 583
samples, respectively, MMAV was not detected in 217
samples, and DMAV was not detected in 46 samples.
Besides imputation of values for non-detect samples,
some samples were missing. For example, 59 partici-
pants did not provide toenail samples; one participant
did not provide urine samples for cotinine and cre-
atinine determinations or data needed for calculation
of BMI.
All non-detect and missing values were imputed in a
manner consistent with the cause of the missing value
and that maintained correlations among analysis
variables. Because imputation has a random component,
results from analysis of imputed data also have a random
component. To minimize the magnitude of the random
component and to calculate standard errors and
confidence intervals that reflect uncertainty in imputed
values, multiple imputations were performed. This
procedure yielded 20 imputed data sets for analysis
[17]. The imputation process is further described in
Additional file 1.
Calculation of analysis variables
The analysis used imputed TiAs, MMA and DMA
concentrations or derived quantities. Urinary iAsIII
and iAsV concentrations were summed for a total iAs
concentration term (TiAs). Urinary TiAs, MMA and
DMA concentrations were summed to create a urin-
ary speciated arsenic concentration term (USAs).
Urinary %TiAs, %MMA, and %DMA were calculated
using USAs as the denominator. A primary methyla-
tion index (PMI) was calculated as the MMAV:TiAs
concentration ratio and a secondary methylation
index (SMI) was calculated as the DMAV:MMAV con-
centration ratio.
Continuous variables were positively skewed and
log10-transformed values were roughly symmetrically
distributed. To yield approximately normally distributed
regression residuals with constant variance, absolute
urinary concentration variables were log10-transformed
and relative urinary concentrations were logit transformed.
Continuous predictor variables were log10-transformed to
make their distributions more normally distributed and to
minimize the influence of particularly large values. Before
log-transforming reported tap water consumption, 93
zeroes were recoded to 0.06 l per day (one-quarter cup).
Unless otherwise noted, categorical variables were recoded
as dummy variables with the reference category coded
as zero.
Bivariate statistical analysis using imputed data
All analysis and data processing were performed with
SAS version 9.4. The 95 % significance level was used
for assessing significant results. For bivariate analyses,
the SAS MIXED procedure was used to estimate means
and correlations and to perform t-tests. The analysis
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procedures were applied to all 20 imputed data sets. The
20 sets of parameter results were passed through the
MIANALYZE procedure to calculate final parameter
estimates, standard errors, and p-values adjusted for the
imputation process. Percentiles were calculated using all
imputed data sets; plots show data from the first
imputed data set.
Comparison of urinary arsenic concentrations in study
participants and NHANES
We compared the distribution of levels of arsenicals
in urine of Churchill County study participants with
the distribution of these levels calculated from nation-
ally representative 2003–2012 NHANES data [18].
Here, we calculated mean log10-transformed concen-
trations of urinary arsenic species for demographic
groups that were used in analysis of Churchill county
data (gender, race (white vs non-white), and age (40
to 49, 50 to 59, 60 to 69, 70 to 79, and 80 years or
older). Means were calculated using survival analysis
(using the LIFEREG procedure with the NHANES
survey weights) to adjust for non-detects. NHANES
data was then reweighted to represent the demo-
graphic distribution of the Churchill County study
population, using the demographic groups identified
above. Mean log10-transformed urinary arsenical con-
centrations (predicted from survival analysis), mean
detection limit for non-detects, and percentage of
non-detects were calculated using revised weights.
Resulting values were used to estimate the NHANES
geometric mean concentrations of urinary arsenical
species, mean detection limits, and percentage of
non-detects for a population similar to the Churchill
County study population. These values were com-
pared to similar statistics calculated from Churchill
County study data using imputed concentrations and
indicators of non-detects. Comparative data for the
Churchill County study and the NHANES survey data
are summarized in Additional file 1.
Multivariate statistical analysis using imputed data
Given the large number of variables in the data set, a
procedure was needed to select independent variables
used to model urinaary arsenic-dependent variables.
This analysis made two assumptions. First, variables
that were significant when modeling one dependent
variable might be important for predicting other
dependent variables. Second, analysis using nine dif-
ferent but related urinary arsenic-dependent variables
would identify the most relevant set of independent
variables for modeling.
This analysis used multiple imputation to provide
estimates of missing values of variables needed for
model development. As described in detail in
Additional file 1, this approach provided plausible
substitute values for missing data and allowed estima-
tion of standard errors that included uncertainty due
to the imputation process. A stepwise selection pro-
cedure identified candidate variables for prediction
of nine dependent variables that are biomarkers of
arsenic exposure (log10-transformed urinary TiAs,
MMA, DMA, and USAs concentrations, PMI, SMI,
and logit-transformed urinary %TiAs, %MMA,
%DMA). Candidate variables included biological fac-
tors (gender, race (white versus other), BMI, age, and
urinary creatinine concentration), behavioral factors
(smoking, recent alcohol consumption, and fish and
seafood consumption) and characteristics of water
consumption (TAs concentration in home tap water
(as a linear and quadratic term), primary home water
source, and daily water consumption). All continuous
predictors were log10-transformed. Standard proce-
dures for stepwise selection of linear regression pre-
dictors from a set of candidate predictors were
adapted for use with multiple imputations. For 180
combinations of nine dependent variables and 20 im-
puted data sets, the SAS GLMSELECT procedure was
applied with default selection criteria, with the excep-
tion that interactions were considered only if the as-
sociated main effects were already in the model. A
candidate predictor that was selected in more than 25
of 180 models was retained for use in the final
model. All candidate variables are listed in the Add-
itional file 1.
The list of selected predictors was reviewed and
revised as follows. Similar smoking-related predictors
(a categorical smoking variable and log10-transformed
urinary cotinine concentration) were selected in dif-
ferent models, necessitating choice of a variable for
final model. Log10-transformed urinary cotinine con-
centration was used in final model development be-
cause it was selected in more imputed data sets and
predicted more dependent variables than did the cat-
egorical smoking variable. This process selected vari-
ous combinations of TAs and predictors related to
water source and water treatment. These combina-
tions were replaced by the interaction of drinking
water source and TAs. Here, drinking water sources
were divided into four self-reported categories: un-
treated tap water that was used without in-home
treatment, filtered tap water subjected to in-home filtration,
tap water that received other in-home treatment (e.g., re-
verse osmosis), or use of commercially bottled water as in-
home water source. Predictive models were developed for
the nine dependent variables, fitting separate intercepts and
slopes for each of the four drinking water source categories
(untreated tap water, filtered tap water, other treatment tap
water, or commercially bottled water).
Hudgens et al. Environmental Health  (2016) 15:62 Page 4 of 14
The stepwise procedure did not select an indicator
of fish and shellfish consumption in the previous
48 h as a predictor (it was selected in 9 of the 180
combinations of dependent variables and imputed
data sets). Because fish and shellfish consumption had
been identified as a significant predictor of urine ar-
senic concentrations in other research [19], the indi-
cator of recent fish and shellfish consumption was
included in the final model.
Non-linear term for TAs concentration
The stepwise regression procedure selected a quadratic
relationship between the dependent variables and the
log10-transformed home tap water TAs concentrations.
Analysis of relations among log10-transformed water
consumption, urinary arsenical concentrations, urinary
creatinine concentration, and home tap water TAs
concentrations indicated the following monotonic
transformation of home tap water TAs concentrations
provided a better fit and accounted for the apparent
quadratic relationship,
Log10 βOffset þWaterAs
 
where βOffset is a positive concentration offset. This non-
linear term defines a monotonic relationship between
water arsenic concentrations and urinary arsenic con-
centrations. The use of an offset term may represent
contributions of sources of arsenic that were not other-
wise represented in the model. Additional details are
provided in Additional file 1.
Modeling effects of biological and behavioral factors and
exposure characteristics on urinary arsenical levels
Because the dependent variables were closely related,
we posited that a variable that was important for pre-
diction of one dependent variable would likely to be
important for prediction of another dependent vari-
able, although this contribution may not be statisti-
cally significant in all models. As a result, the same
final model was fitted to all independent variables.
The offset parameter for water arsenic concentration
(βOffset) was modeled using the log10-transformed off-
set (αLogOffset) to avoid negative offset values and im-
prove convergence.
The final model used to predict log-transformed
biomarkers of exposure to arsenic (Y) is described by
the following equation:
In this analysis, separate intercept (αDWS) and slope
(βDWS) parameters were fitted for the four drinking
water source categories. Although urinary concentra-
tions of either arsenicals or cotinine were not corrected
for creatinine concentration, creatinine was included in
the multivariate model as a predictor. As a result, the
parameters in the multivariate model represent the
relationship between concentrations after adjusting for
any effect of creatinine on the measurements. Tap water
consumption is the self-estimated daily amount to tap
water consumed, whether treated or untreated. For this
analysis, recent fish or shellfish consumption was de-
fined as self-reported consumption during the previous
48 h. It was scored as 1 if the subject participant
reported consumption or as 0 if consumption did not
occur. This non-linear model was fitted to each of the
20 imputed datasets using the SAS NLIN procedure.
The 20 sets of parameter results were passed through
the MIANALYZE procedure to calculate final parameter
estimates, standard errors, and p-values adjusted for the
imputation process.
Results
Of 904 study participants, 59 % were female, most
(84 %) were non-smokers, and 55 % of participants were
60 years of age or older. A full account of the character-
istics of study participants has been presented [1]. For
all study participants, home tap water TAs concentra-
tions were used as the measure of exposure. Figure 1
shows urinary log10-transformed TiAs, MMA, and DMA
concentrations and logit-transformed %TiAs, %MMA,
and %DMA as functions of log10-transformed home tap
water TAs concentrations. Increasing home tap water
TAs concentrations were significantly associated with in-
creasing urinary TiAs, MMA, and DMA concentrations.
In contrast, urinary %TiAs, %MMA, and %DMA which
varied widely among participants were not significantly
correlated with home tap water TAs concentration.
Based on the 1st and 99th percentiles, %TiAs ranged
from 4.4 to 37.9 %, %MMA from 5.9 to 29.3 %, and
%DMA from 47.4 to 86.0 %. Figure 2 shows the relation
of PMI and SMI values to log10-transformed home tap
water TAs concentrations. Based on the 1st and 99th
percentiles, PMI ranged from 0.22 to 4.02 and SMI
ranged from 1.81 to 13.49. Neither methylation index
significantly correlated with home tap water TAs
concentration.
Log10ðY Þ ¼ αDWS þ βDWS

Log10ð10αLogOf f set þWaterAsÞ

þ βQLog10ðTap water consumptionÞ
þ βCLog10ðCreatinineÞ þ βFFemaleþ βBLog10ðBMIÞ þ βALog10ðAgeÞ
þ βSLog10ðCotinineÞ þ βRLog10 ðRecent f ish consumptionÞ:
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Notably, among study participants, concentrations of
some urinary analytes were below LODs. The species
with the highest rates of non-detection were iAsV (64 %
of urine samples) and iAsIII (32 % of urine samples).
MMA was not detected in 24 % of urine samples and
DMA was not detected in 5 % of urine samples. Absence
of quantifiable levels of these metabolites in urine
prompted the imputation of values used in data modeling.
To evaluate the significance of non-detect levels of
arsenicals in urine, we compared distributions of urinary
concentrations of arsenicals and frequencies of non-
detect levels in study participants with corresponding
values calculated with 2003–2012 NHANES survey data.
As summarized in Additional file 1, geometric mean
urinary concentrations of MMA, and DMA for study
participants were 5.6 to 7.9 times higher than corre-
sponding values calculated from NHANES survey data.
Similarly, percentages of non-detect values for each ar-
senical in urine were much higher in NHANES survey
than in study participants.
Relations between NTAs and urinary TiAs, MMA, or
DMA concentrations were examined (Fig. 3). Over the
100-fold range of NTAs concentrations, there were a
significant positive correlations (P < 0.0001) between
NTAs concentrations and urinary concentrations of each
arsenical.
Gender significantly correlated with absolute and
relative concentrations of TiAs and its methylated
Fig. 1 Relations between arsenic concentrations in home tap water and absolute or relative concentrations of arsenicals in urine. Panels a, b, and c
show relations between home tap water arsenic concentration and urinary concentration of (a) inorganic arsenic, iAs, (b) monomethylated arsenic,
MMA, and (c) dimethylated arsenic, DMA. Arsenic concentrations in home tap water and in urine expressed as parts per billion (ppb, μg per l). For
each arsenical, there was a statistically significant correlation between arsenic levels in home tap water and in urine. Panels d, e, and f show relations
between home tap water arsenic concentration and percentage of urinary speciated arsenic concentration accounted for by d iAs, e MMA, and (f)
DMA. The red line in each panel encloses 95 % of data
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metabolites in urine (Table 1). Compared to males,
females had significantly lower urinary concentrations of
TiAs, MMA, and DMA (P ≤ 0.0009), %TiAs (P = 0.0046)
and %MMA (P < 0.0001). In contrast, urinary %DMA in fe-
males was significantly higher than in males (P < 0.0001).
The geometric mean PMI was not significantly correlated
with gender; however, the geometric mean SMI was signifi-
cantly higher (P < 0.0001) in females than in males.
Enrollment criteria for this study yielded a sample in
which 45 % of participants were from 45 to 59 years old
Fig. 2 Relations between arsenic concentrations in home tap water
and primary and secondary methylation indices. Panel a shows the
relation between home tap water arsenic levels and the primary
methylation index. Arsenic concentrations in home tap water
expressed as parts per billion (ppb, μg per l). Panel b shows the
relation between home tap water arsenic levels and the secondary
methylation index. The red line in each panel encloses 95 % of data
Fig. 3 Relation between concentrations of total arsenic in nails and
concentrations of inorganic arsenic and its methylated metabolites in
urine, a iAs, b MMA, and c DMA. Arsenic concentrations expressed
as parts per million (ppm, μg per g) in nails and as parts per billion
(ppb, μg per l) in urine
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and 55 % from 60 to 92 years old. The median age of
study participants was 61 years. There was a significant
age-dependent trend for lower urinary TiAs concen-
tration (P = 0.0072). Although urinary MMA and
DMA concentrations declined with increasing age,
these trends were not statistically significant. Increas-
ing age significantly correlated with PMI (P = 0.0002)
but not with SMI. There were significant age-related
trends for decreased %TiAs (P < 0.0001) and increased
%DMA (P < 0.0029) in urine.
No statistically significant relations were found
between BMI and urinary TiAs, MMA, or DMA
concentrations. Increased BMI was associated with
significantly decreased %MMA (P < .0001), signifi-
cantly increased %DMA (P = 0.0002), significantly
lower PMI (P = 0.0013), and significantly higher SMI
(P < 0.0001).
Smoking frequency, estimated by urinary cotinine
concentration, was associated with significantly in-
creased urinary TiAs, MMA, and DMA concentra-
tions (P ≤ 0.0001), and urinary %TiAs (P = 0.0013),
and %MMA (P = 0.0185), but with decreased urinary
%DMA (P < 0.0001). Smoking frequency was not asso-
ciated with PMI but was associated with significantly
decreased SMI (P = 0.0016).
The questionnaire completed by study participants
collected information on recent (i.e., within 48 h)
consumption of fish or shellfish. The current analysis ex-
amined whether recent consumption of fish or shellfish
affected absolute or relative levels of inorganic or
methylated arsenicals in urine. In this study population,
no significant bivariate relations were seen between in-
take of these seafoods and levels of speciated arsenicals
in urine.
The final model predicted log10-transformed urinary
TiAs, MMA, DMA, USAs concentrations, logit-
transformed urinary %TiAs, %MMA, and %DMA, and
log10-transformed methylation indices, PMI and SMI.
Parameter estimates for the model are shown in Tables 2
and 3. Because the same model was fitted to all
dependent variables that are biomarkers of exposure to
arsenic, parameter estimates can be compared across
Table 1 Effects of gender on absolute and relative levels of
arsenicals in urine
Arsenical Gender P-valuea
Male Female
TiAs Geometric mean (μg/l) 2.070 1.737 <.0001
Mean % 15.7 14.1 0.0046
MMA Geometric mean (μg/l) 2.204 1.789 <.0001
Mean % 17.3 14.5 <.0001
DMA Geometric mean (μg/l) 4.041 3.661 0.0009
Mean % 67.1 71.4 <.0001
Methylation Index (Geometric mean)
Primary 1.065 1.030 0.1308
Secondary 1.834 2.046 <.0001
aP-values for the geometric mean differences are based on analysis of the
log10-transformed values. P-values for mean percentage differences are
based on analysis of the logit transformed percentages
Table 2 Model parameter estimates of concentrations of arsenicals in urinea
Parameter Arsenical
Log10 (TiAs) Log10 (MMA) Log10 (DMA) Log10 (USAs)
Intercept Untreated tap −1.068* (0.504) −1.337* (0.453) −1.70** (0.382) −1.208* (0.382)
Filtered −1.328* (0.574) −1.561* (0.506) −2.068** (0.439) −1.529*** (0.436)
Other treatment −0.382 (0.448) −0.703 (0.410) −1.077* (0.344) −0.568 (0.344)
Bottled −0.291 (0.447) −0.699 (0.405) −1.05* (0.339) −0.529 0.338)
Transformed Water TAs Slope Untreated tap 0.813** (0.121) 0.817** (0.105) 0.776** (0.091) 0.791** (0.091)
Filtered 0.978** (0.177) 0.945** (0.152) 0.978** (0.138) 0.969** (0.136)
Other treatment 0.342*** (0.088) 0.346** (0.081) 0.305** (0.067) 0.317** (0.068)
Bottled 0.289*** (0.074) 0.345** (0.065) 0.309** (0.055) 0.306** (0.055)
Log10 (Water TAs offset) 1.244** (0.220) 1.20** (0.194) 1.206** (0.175) 1.212** (0.172)
Log10 (Tap water consumption) 0.102* (0.033) 0.139** (0.029) 0.136** (0.024) 0.130** (0.024)
Log10 (Creatinine) 0.580** (0.046) 0.714** (0.041) 0.732** (0.033) 0.706** (0.033)
Gender (Female = 1, Male = 0) −0.049 (0.027) −0.061* (0.024) 0.056* (0.020) 0.023 (0.020)
Log10 (BMI) −0.147 (0.156) −0.628* (0.140) −0.072 (0.118) −0.164 (0.117)
Log10 (Age) −0.360* (0.169) 0.101 (0.150) 0.211 (0.129) 0.118 (0.129)
Log10 (Cotinine) 0.054** (0.012) 0.031* (0.011) 0.023* (0.009) 0.029* (0.009)
Fish or shellfish consumption within 48 h 0.030 (0.028) 0.011 (0.025) 0.039 (0.021) 0.034 (0.021)
aParameter estimates with standard errors in parentheses. Significance levels for estimates: P < 0.0001-***; 0.0001 < P < 0.001-**; 0.05 > P > 0.001-*
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models. Figure 4 shows predicted relations between
home tap water TAs concentrations and urinary TiAs,
MMA, and DMA concentrations for each water use
group and includes a histogram of home TAs concentra-
tions for each drinking water source category. Predicted
relationships shown in Fig. 4 were calculated by setting
values for gender and all log10-transformed continuous
variables except home water TAs concentrations to their
mean across all respondents.
Many parameters, particularly slope parameters for
transformed TAs concentration in the drinking water
source, significantly predicted urinary biomarkers of
arsenic exposure. As home tap water TAs concentrations
and tap water consumption increased, urinary concen-
trations of arsenicals increased, other factors being
constant. Higher urinary concentrations of arsenicals
were associated with use of untreated tap water or fil-
tered tap water compared to use of other treatment
tap water or bottled water. Smoking frequency as
reflected by urinary cotinine concentration increased
urinary concentrations of arsenicals, especially TiAs.
Increasing BMI was associated with lower urinary ar-
senical concentrations, although this relationship was
statistically significant for only MMA. Influences of
age and gender on urinary arsenical concentrations
were less significant and inconsistent in direction
among different dependent variables. Self-reported re-
cent consumption of fish or shellfish consumption
was not a significant predictor of any of the arsenic-
dependent variables.
A similar approach was taken to analyze statistical sig-
nificance of parameter estimates in prediction of relative
urinary arsenical concentrations or of methylation indi-
ces (Table 3). Neither transformed TAs concentration
nor tap water consumption significantly predicted these
dependent variables. Differences in intercepts or slopes
were not statistically significant among drinking water
sources. When log10-transformed TAs concentration
was not a significant predictor, the offset parameter was
also not significant or important to the model. This
observation, coupled with difficulties in estimating the
offset, lead to its removal from the final model for pre-
dicting relative concentrations. Females and older re-
spondents had relatively less arsenic as iAs and MMA
and more as DMA. Those with higher BMI had
relatively less arsenic as MMA and more as DMA.
Higher urinary cotinine concentrations were associated
with higher levels of iAs in urine.
Discussion
In the following sections, the influence of biological and
behavioral factors on conversion of iAs into methylated
metabolites are considered singly and as they contribute
to a multivariate regression model that characterized
significant factors associated with interindividual
metabolic capacity.
As in the earlier analysis of data from study participants
[1], the current analyses used urinary concentrations of
arsenicals that were not corrected for creatinine concen-
tration. Urinary creatinine concentration is related to age
Table 3 Model parameter estimates of relative urinary arsenic levels and methylation indicesa
Parameter Arsenical Methylation index
Logit (%TiAs) Logit (%MMA) Logit (%DMA) Log10 (PMI) Log10 (SMI)
Intercept Untreated tap 0.969 (0.689) 0.178 (0.496) −1.867** (0.459) −0.311 (0.348) −0.387 (0.214)
Filtered 1.136 (0.711) 0.369 (0.509) −2.114** (0.479) −0.295 (0.353) −0.492* (0.221)
Other treatment 1.047 (0.676) 0.239 (0.489) −1.962** (0.458) −0.315 (0.339) −0.424* (0.213)
Bottled 1.138 (0.700) 0.113 (0.500) −1.965** (0.459) −0.387 (0.355) −0.380 (0.215)
Transformed Water TAs Slope Untreated tap 0.012 (0.063) 0.062 (0.042) −0.053 (0.041) 0.020 (0.031) −0.031 (0.018)
Filtered −0.033 (0.128) −0.049 (0.087) 0.065 (0.085) −0.009 (0.061) 0.028 (0.038)
Other treatment 0.045 (0.073) 0.024 (0.055) −0.047 (0.053) −0.006 (0.035) −0.015 (0.024)
Bottled −0.063 (0.073) 0.070 (0.052) 0.011 (0.053) 0.046 (0.034) −0.023 (0.023)
Log10 (Water TAs offset)
Log10 (Tap water consumption) −0.079 (0.055) 0.023 (0.039) 0.039 (0.038) 0.037 (0.027) −0.003 (0.017)
Log10 (Creatinine) −0.341** (0.078) 0.019 (0.054) 0.193*** (0.051) 0.133* (0.039) 0.018 (0.023)
Gender (Female = 1, Male = 0) −0.195** (0.046) −0.226** (0.031) 0.257** (0.029) −0.012 (0.022) 0.117** (0.013)
Log10 (BMI) 0.055 (0.270) −1.257** (0.183) 0.736** (0.173) −0.478*** (0.133) 0.554** (0.079)
Log10 (Age) −1.277** (0.272) −0.040 (0.189) 0.719*** (0.188) 0.461*** (0.131) 0.110 (0.084)
Log10 (Cotinine) 0.067*** (0.019) 0.007 (0.014) −0.046*** (0.014) −0.023* (0.009) −0.008 (0.006)
Fish or shellfish consumption within 48 h −0.011 (0.047) −0.061 (0.032) 0.040 (0.032) −0.019 (0.023) 0.028 (0.014)
aParameter estimates with standard errors in parentheses. Significance levels for estimates: P < 0.0001-***; 0.0001 < P < 0.001-**; 0.05 > P > 0.001-*
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[20, 21]. An earlier study found that creatinine correction
of arsenic concentrations in urine did not improve expos-
ure estimates [22] and adjustment for urinary creatinine
concentration resulted in overestimation of urinary
arsenic levels in individuals with type 2 diabetes [23]. Not-
ably, our earlier analysis found urinary creatinine
concentration to be a significant predictor of the sum of
concentrations of speciated arsenicals in study participants
[1]. This relation likely reflects interactions between
creatinine metabolism and the enzymatically catalyzed
reactions that methylate arsenic [24, 25] as well as factors
affecting urine dilution.
The relation between extent of exposure to arsenic as
exemplified by TAs concentrations in home tap water
supplies and urinary TiAs, MMA, and DMA concentra-
tions was examined in study participants with home TAs
concentrations up to 1,850 μg per liter. Over this expos-
ure range, there were significant correlations between
concentrations of TAs in home tap water supplies and
urinary TiAs, MMA, and DMA concentrations. These
correlations were also found in a Bengladeshi population
with a similar range of concentrations of TAs in drinking
water supplies [26]. In contrast, relative levels of TiAs,
MMA, and DMA in urine were not correlated with home
tap water TAs concentrations. A lack of correlation
between concentration of arsenic in drinking water and
relative levels of urinary arsenicals has been previously
reported [27]. The relation between intensity of exposure
to iAs and the relative levels of inorganic and methylated
arsenicals in urine can be evaluated as a reflection of the
characteristics of reactions that methylate arsenic. These re-
actions are catalyzed by arsenic (+3 oxidation state) methyl-
transferase (AS3MT) and require S-adenosylmethionine
(AdoMet) as the methyl group donor [28]. Upregulated
AS3MT gene expression or AdoMet availability may be
major determinants of capacity for arsenic methyla-
tion [29, 30]. Capacity for AS3MT-catalyzed conversion
of iAs into methylated metabolites is apparently quite
high. In workers exposed to arsenic fume and dust with
estimated daily respired doses of arsenic up to 4000 μg,
neither absolute nor relative iAs, MMA, and DMA con-
centrations in urine showed evidence of saturation [31].
However, under some situations, the capacity for enzymat-
ically catalyzed methylation of arsenic may be saturated.
In an iAs-exposed Bengaldeshi population, insufficient
dietary intake of folic acid or folate and cobalamin affected
Fig. 4 Concentrations of inorganic arsenic and its methylated metabolites in urine predicted by multivariate regression model. Levels of inorganic
arsenic (iAs), monomethylated arsenic (MMA), and dimethylated arsenic (DMA) in urine predicted for users of home tap water that is untreated
a, filtered b, or receives other treatment c and users of commercially bottled water d. Histogram (gray line) shows distribution of home tap water
TAs concentrations for each user group. Arsenic concentrations in home tap water and in urine expressed as parts per billion (ppb, μg per l)
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folate- and cobalamin-dependent one-carbon metabolism,
diminished AdoMet availability, and limited AS3MT-
catalyzed conversion of iAs into its methylated metabo-
lites [30]. Although neither folate nor cobalamin nutriture
was evaluated in the current study, evidence from con-
temporaneous NHANES surveys suggest that among
study participants folic acid/folate intake was likely suffi-
cient [32] and cobalamin deficiency was probably uncom-
mon [33]. In addition to the biological and behavioral
factors considered in this study, polymorphisms of
AS3MT in humans that alter catalytic properties of the
methyltransfersase [34] can contribute to interindividual
differences in urinary profiles of iAs and its methylated
metabolites [7]. Although a comprehensive study of the
role of AS3MT genotypic variation was beyond the scope
of the current study, a pilot study summarized in
Additional file 1 demonstrated that common AS3MT
polymorphisms affected methylation capacity in study
participants.
This study found no significant relationship between
home tap water TAs concentration and either methyla-
tion index. Methylation indices are phenotypic indicators
of arsenic methylation ability [35] and are widely used as
stratifiers in population-based studies of adverse health
effects associated with chronic arsenic exposure (e.g.,
[36, 37]). The ratios PMI and SMI are dimensionless
quantities that may not reflect exposure-dependent
changes in arsenic methylation efficiency. Furthermore,
evaluation of urinary levels of speciated arsenicals from
2009–2010 NHANES survey data found seafood con-
sumption can increase DMA intake [38]. Because DMA
derived from seafood does not originate by conversion
of iAs to methylated metabolites, its contribution to
urinary DMA could affect the calculation of the SMI by
increasing the denominator. Variation in PMI values
(over 18-fold) and SMI values (over seven-fold) may re-
flect uncharacterized sources of exposure to arsenicals
and confound the relation between exposure to iAs from
home tap water supplies and metabolic indices.
Increased urinary TiAs, MMA, and DMA concentrations
were associated with increasing NTAs concentrations. This
finding is consistent with reports of strong correlations be-
tween NTAs concentration and either USAs concentrations
or summed concentrations of all arsenicals in urine [1, 39].
NTAs concentrations have been positively associated with
increasing exposure to arsenic from drinking water and
food [40–43], although this relation can be modified by
nutritional status or genotype [39, 40, 44]. The relation
between urinary concentrations of speciated arsenicals and
forms and concentrations of arsenic in nails remains
unclear. Arsenic is concentrated in dorsal and ventral
surfaces of nails in association with sulfur-rich molecules,
especially keratin [45]. More than 85 % of arsenic in aque-
ous extracts of nails is iAs; DMA accounts for the balance
[46]. Thus, although arsenic retained in nails may inte-
grate exposure over longer timeframe than does arsenic in
urine, it is unclear whether nails are useful biomarkers to
reconstruct patterns of exposure to inorganic and methyl-
ated arsenicals [47, 48].
Among study participants, males reported significantly
higher home tap water and total water consumption
than did females [1]. This gender difference in water in-
take was reflected in higher urinary TiAs, MMA, and
DMA concentrations in males than in females. Urinary
%TiAs, %MMA, and %DMA also differed in males and
females. Consistent with this study, a gender difference
in urinary excretion of methylated arsenicals was found
in a Bangladeshi population where the mean SMI in
females was significantly higher than in males [49]. This
between-gender difference in methylation efficiency was
attributed to the influence of sex hormones. Because the
median age of study participants (61 years) was higher
than the median age at menopause (52.54 years) in the
U.S. [50], it is unclear whether menopause per se was a
factor in the gender difference in methylation capacity.
Notably, between-gender differences in absolute and
relative urinary concentrations of methylated arsenicals,
particularly MMA, has been linked to gender differences
in the prevalence of adverse health effects associated
with chronic exposure to iAs [51].
Age-dependent trends for lower urinary TiAs, MMA,
and higher DMA concentrations were reflected in
altered relative urinary arsenical levels. Notably, our
earlier analysis of age-stratified data found no statisti-
cally significant trends for USAs concentrations among
study participants [1]. Median BMIs for male and female
study participants were 28.0 and 28.8, respectively.
These values are comparable with NHANES 1999–2002
results [52] for males (mean BMI by decade of 26.8 to
28.7) and females (mean BMI by decade of 26.8 to 29.2).
Among study participants, increasing BMI was not
correlated with urinary TiAs, MMA, and DMA concentra-
tions but was associated with decreased urinary %MMA
and increased %DMA. Notably, a reported association be-
tween increased BMI and lower levels of arsenic in nails
[53] suggests that obesity may alter arsenical distribution
and retention. Consistent with this study, associations
between increased BMI and decreased urinary %MMA or
increased %DMA were found in the Strong Heart Study
cohort of adult residents of rural U.S. midwestern and
southwestern communities [54] and in a cohort of adult
women from the U.S. southwest and northwest Mexico
[55, 56]. An interaction between elevated BMI and cancer
risk in iAs-exposed adults has recently been described in a
South American population [57].
Cigarette smoking was associated with increased absolute
and relative urinary TiAs, MMA, and DMA concentrations
and altered methylation indices. The contribution of arsenic
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in tobacco to aggregate exposure does not account for
smoking’s effect on urinary arsenical levels. An
NHANES 1999–2002 estimate of usual daily con-
sumption of 16 cigarettes [58] and the amount of
arsenic (0.0104 μg) in smoke generated from a refer-
ence cigarette [59] yields an exposure of 0.17 μg of
arsenic per day. For an individual daily consuming
two liters of drinking water containing arsenic at the
current MCL (10 μg per l), the contribution of
arsenic from cigarette smoking to aggregate exposure
is nugatory (~0.8 % of total daily exposure). Hence,
the association between smoking and higher levels of
arsenicals in urine must reflect smoking-induced
alterations that alter urinary clearance of arsenicals.
Notably, dose–response relations for lung cancer
relative risks are similar for inhaled or ingested iAs,
suggesting that common metabolic and kinetic pro-
cesses must determine the distribution and clearance
of absorbed iAs or its metabolites that induce lung
cancer [60]. The modifying effect of tobacco use on
arsenic metabolism is an important public health issue
because smoking and arsenic exposure have synergistic
effects on lung and urinary bladder cancer and cardiovas-
cular disease risk [61–63]. Similar to effects associated
with active smoking, passive exposure to environmental
tobacco smoke has also been associated with changes in
SMI and the risk of urinary bladder cancer in individuals
chronically exposed to iAs [64].
Seafood, including finfish and shellfish, can be signifi-
cant dietary sources of inorganic or methylated arseni-
cals [65]. Analysis of dietary consumption data for U.S.
populations found that total arsenic levels in urine were
higher in individuals with seafood consumption within
the last 24 h [66, 67]. In seafood consumers, the largest
contributors to increased urinary total arsenic were
arsenobetaine and dimethylated arsenic. Increased levels
of urinary dimethylated arsenic may reflect degradation
of complex organic arsenicals in seafoods [67]. We pre-
viously found that recent seafood consumption signifi-
cantly increased urinary total arsenic levels but not
increase USAs levels [1]. In the stepwise general linear
model, seafood consumption significantly predicted
urinary total arsenical but not USAs or NTAs concentra-
tions. In the present study, the failure to detect a contri-
bution of recent seafood consumption to levels of
inorganic or methylated arsenicals in urine may reflect
the low rate of recent seafood consumption among study
participants (29 % within the last 48 h) or that the pre-
dominant species of arsenic in consumed seafood was
neither a dimethylated arsenical nor a species that can
be metabolized to dimethylated arsenical.
This analysis found that both biological and behavioral
factors were significant predictors of absolute and
relative levels of iAs, MMA, and DMA in urine. Because
metabolism of iAs is linked to formation of methylated
metabolites that likely mediate some of the adverse
health effects associated with chronic exposure to iAs
[6, 7], attempts to elucidate dose–response relations
in population-based studies should consider potentially
modifying effects of these factors. Accounting for these
factors will improve assessment of risk associated with
chronic exposure to iAs. Notably, in the multivariate
regression model for the urinary concentrations of TiAs,
MMA, DMA, and USAs practically all parameter
estimates were statistically significant, suggesting that
water source and consumption as well as a wide range of
biological and behavioral factors influenced levels of these
analytes in urine. In contrast, the multivariate regression
models for %TiAs, %MMA, %DMA, and for the methyla-
tion indices PMI and SMI yielded a smaller set of param-
eter estimates that were statistically significant. Here,
primarily biological and behavioral factors were the signifi-
cant predictors of the response variables, suggesting that
these factors modify the capacity to convert iAs to its
methylated metabolites over a wide range of exposure
conditions.
Conclusions
Among study participants from a U.S. population with
long histories of exposure to TAs from home tap water
sources, we found that urinary levels of iAs and its
mono- and di-methylated metabolites were predicted by
age, gender, BMI, and smoking. A multivariate regression
model of these data indicated that relative amounts of
arsenical species in urine were also predicted by these
biological and behavioral factors. Given the critical role of
methylated arsenicals as mediators of the toxic and
carcinogenic effects associated with exposure to iAs, this
analysis underlines the need to evaluate potentially modi-
fying effects of these factors in population-based studies of
adverse health effects of this metalloid.
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